A phase II trial of second-line axitinib following prior antiangiogenic therapy in advanced hepatocellular carcinoma
McNamara, Mairéad G., Le, Lisa W., Horgan, Anne M., Aspinall, Alex, Burak, Kelly W., Dhani, Neesha, Chen, Eric, Sinaei, Mehrdad, Lo, Glen, Kim, Tae Kyoung, Rogalla, Patrik, Bathe, Oliver F., Knox, JenVolume:
121
Language:
english
Journal:
Cancer
DOI:
10.1002/cncr.29227
Date:
May, 2015
File:
PDF, 275 KB
english, 2015